Zydus Lifesciences Completes 85.6% Stake Acquisition in Amplitude Surgical SA for €256.8 Million

Zydus Lifesciences Limited, an Indian pharmaceutical company, has completed the acquisition of a controlling 85.6% stake in Amplitude Surgical SA, a French medical device company, for a total consideration value of €256.8 million. The acquisition was carried out through Zydus MedTech (France) SAS, a wholly owned subsidiary of Zydus MedTech Private Limited, which is a subsidiary of Zydus Lifesciences Limited. The acquisition was completed on July 29, 2025, following the fulfillment of all conditions precedent. Zydus MedTech France will now file a simplified mandatory tender offer for all the remaining outstanding shares of Amplitude Surgical SA at a price of €6.25 per share. Upon completion of the tender offer, Zydus MedTech France is expected to hold more than 90% of the capital and voting rights of Amplitude Surgical SA, leading to a subsequent delisting of the company.